Preemptive interleukin-6 blockade in patients with COVID-19

Guillen, L; Padilla, S; Fernandez, M; Agullo, V; Garcia, JA; Telenti, G; Garcia-Abellan, J; Botella, A; Gutierrez, F; Masia, M

Gutierrez, F; Masia, M (corresponding author), Univ Miguel Hernandez, Clin Med Dept, Ctra Valencia N-322,Km 87, Alacant 03550, Spain.; Gutierrez, F; Masia, M (corresponding author), Univ Miguel Hernandez, Avda Univ S-N, Alicante 03202, Spain.

SCIENTIFIC REPORTS, 2020; 10 (1):

Abstract

Excessive interleukin-6 signaling is a key factor contributing to the cytokine release syndrome implicated in clinical manifestations of COVID-19. Pre......

Full Text Link